Last reviewed · How we verify

NCT03651414: SISIFO

Safety Issues and SurvIval For Medical Outliers

Terminated Last updated 10 February 2025
What this trial tests

trial testing Clinical data collection in Hospitalization in 2,056 participants. Terminated before completion.

Timeline
19 October 2018
Primary endpoint
7 April 2020
7 July 2020

Quick facts

Lead sponsorFadoi Foundation, Italy
StatusTerminated
Study typeOBSERVATIONAL
Enrollment2,056
Start date19 October 2018
Primary completion7 April 2020
Estimated completion7 July 2020
Sites32 locations across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Fadoi Foundation, Italy

Who can join

18 and older, any sex, with Hospitalization. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Each Investigator will have to record data concerning 70 patients. In particular 40 patients "outliers" and 30 patients "control".

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. What Quality and Safety of Care for Patients Admitted to Clinically Inappropriate Wards: a Systematic Review.
    La Regina M, Guarneri F, Romano E, Orlandini F, et al · · 2019 · cited 20× · PMID 31011980 · DOI 10.1007/s11606-019-05008-4

Verify or expand the search:

Other trials of Clinical data collection

Trials testing the same drug.

Other recruiting trials for Hospitalization

Currently open trials in the same condition.

Other Fadoi Foundation, Italy trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03651414.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing